Page last updated: 2024-11-12

cerevisterol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cerevisterol: in mushroom family; Russian [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cerevisterol : An ergostanoid that is (22E)-ergosta-7,22-diene substituted by hydroxy groups at positions 3, 5 and 6 (the 3beta,5alpha,6beta stereoisomer). It has been isolated from the fungus, Xylaria species. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10181133
CHEMBL ID491546
CHEBI ID68083
SCHEMBL ID3277925
MeSH IDM0049812

Synonyms (22)

Synonym
cerevisterol
516-37-0
CHEMBL491546
chebi:68083 ,
ergosta-7,22e-diene-3beta,5alpha,6beta-triol
6mhq9j8e6j ,
unii-6mhq9j8e6j
ergosta-7,22-diene-3,5,6-triol, (3beta,5alpha,6beta,22e)-
cerevisterin
(22e)-ergosta-7,22-diene-3beta,5alpha,6beta-triol
SCHEMBL3277925
mfcd08274564
FS-9952
Q15410887
(3s,5r,6r,9s,10r,13r,14r,17r)-17-[(e,2r,5r)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,3,4,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,5,6-triol
5alpha-ergosta-7,22-diene-3beta,5,6-triol
HY-N3571
CS-0023859
(3beta,5alpha,6beta,22e)-ergosta-7,22-diene-3,5,6-triol
5alpha-ergosta-7,22-diene-3beta,5,6beta-triol
DTXSID001045318
AKOS040760066
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Aspergillus metaboliteAny fungal metabolite produced during a metabolic reaction in the mould, Aspergillus.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
3beta-hydroxy steroidA 3-hydroxy steroid in which the 3-hydroxy substituent is in the beta-position.
5alpha-hydroxy steroid
6beta-hydroxy steroidAny 6-hydroxy steroid in which the 6-hydroxy substituent has beta-configuration.
ergostanoid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID379023Cytotoxicity against human HCT15 cells2006Journal of natural products, Jan, Volume: 69, Issue:1
5,6:8,9-diepoxy and other cytotoxic sterols from the marine sponge Homaxinella sp.
AID652956Inhibition of NGF-mediated neurite outgrowth in rat PC12 cells after 24 hrs by light microscopy2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Scabronine M, a novel inhibitor of NGF-induced neurite outgrowth from PC12 cells from the fungus Sarcodon scabrosus.
AID606225Antifungal activity against Candida albicans SC5314 at 100 ug/mL after 16 hrs by CLSI M-27A broth microdilution method in presence of 0.004 ug/mL ketoconazole relative to compound alone2011Journal of natural products, May-27, Volume: 74, Issue:5
Isolation and structural elucidation of proline-containing cyclopentapeptides from an endolichenic Xylaria sp.
AID379019Cytotoxicity against human A549 cells2006Journal of natural products, Jan, Volume: 69, Issue:1
5,6:8,9-diepoxy and other cytotoxic sterols from the marine sponge Homaxinella sp.
AID379021Cytotoxicity against human SK-MEL-2 cells2006Journal of natural products, Jan, Volume: 69, Issue:1
5,6:8,9-diepoxy and other cytotoxic sterols from the marine sponge Homaxinella sp.
AID606223Antifungal activity against Candida albicans SC5314 at 100 ug/mL after 16 hrs by broth microdilution method2011Journal of natural products, May-27, Volume: 74, Issue:5
Isolation and structural elucidation of proline-containing cyclopentapeptides from an endolichenic Xylaria sp.
AID1256624Effect on neurite outgrowth in rat PC12 cells at 10 and 20 uM after 48 hrs by inverted microscopic analysis2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells.
AID379022Cytotoxicity against human XF498 cells2006Journal of natural products, Jan, Volume: 69, Issue:1
5,6:8,9-diepoxy and other cytotoxic sterols from the marine sponge Homaxinella sp.
AID379020Cytotoxicity against human SKOV3 cells2006Journal of natural products, Jan, Volume: 69, Issue:1
5,6:8,9-diepoxy and other cytotoxic sterols from the marine sponge Homaxinella sp.
AID1256621Cytotoxicity against rat PC12 cells assessed as cell viability at 10 and 20 uM after 72 hrs by SRB assay2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells.
AID1256622Stimulation of NGF-mediated neurite outgrowth in rat PC12 cells at 10 and 20 uM after 48 hrs by inverted microscopic analysis2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (35.00)29.6817
2010's11 (55.00)24.3611
2020's2 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.17 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]